Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 27;12(5):1876.
doi: 10.3390/jcm12051876.

Type 2 Diabetes Prevention Programs-From Proof-of-Concept Trials to National Intervention and Beyond

Affiliations
Review

Type 2 Diabetes Prevention Programs-From Proof-of-Concept Trials to National Intervention and Beyond

Jaakko Tuomilehto et al. J Clin Med. .

Abstract

The prevention of type 2 diabetes (T2D) in high-risk people with lifestyle interventions has been demonstrated by several randomized controlled trials. The intervention effect has sustained up to 20 years in post-trial monitoring of T2D incidence. In 2000, Finland launched the national T2D prevention plan. For screening for high T2D risk, the non-laboratory Finnish Diabetes Risk Score was developed and widely used, also in other countries. The incidence of drug-treated T2D has decreased steadily since 2010. The US congress authorized public funding for a national diabetes prevention program (NDPP) in 2010. It was built around a 16-visit program that relies on referral from primary care and self-referral of persons with either prediabetes or by a diabetes risk test. The program uses a train-the-trainer program. In 2015 the program started the inclusion of online programs. There has been limited implementation of nationwide T2D prevention programs in other countries. Despite the convincing results from RCTs in China and India, no translation to the national level was introduced there. T2D prevention efforts in low-and middle-income countries are still limited, but results have been promising. Barriers to efficient interventions are greater in these countries than in high-income countries, where many barriers also exist. Health disparities by socioeconomic status exist for T2D and its risk factors and form a challenge for preventive interventions. It seems that a stronger commitment to T2D prevention is needed, such as the successful WHO Framework Convention on Tobacco Control, which legally binds the countries to act.

Keywords: diabetes prevention; impaired glucose tolerance; national implementation; proof-of-concept trials.

PubMed Disclaimer

Conflict of interest statement

J.T. owns stocks in Orion Pharma and Aktivolabs. MU owns stocks in Orion Pharma. Other authors have reported no other potential conflict of interest relevant to this article.

Figures

Figure 1
Figure 1
Age-standardized (The Finnish age distribution as standard) incidence of new reimbursement rights for glucose-lowering drug treatment by the Finnish Social Insurance Institution in the FIN-D2D study areas and the rest of Finland.

References

    1. Joslin E. The prevention of diabetes mellitus. JAMA. 1921;76:79–84.
    1. Hamman R. Prevention of Type 2 diabetes. In: Williams R., Herman W., Kinmonth A.L., Wareham N.J., editors. The Evidence for Diabetes Care. John Wiley & Sons; Chichester, NY, USA: 2002. pp. 75–176.
    1. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057. doi: 10.2337/diab.28.12.1039. - DOI - PubMed
    1. WHO . World Health Organization Expert Committee on Diabetes Mellitus. Second Report. WHO Tech Rep Ser 646. WHO; Geneva, Switzerland: 1980. - PubMed
    1. Tuomilehto J., Wolf E. Primary prevention of diabetes mellitus. Diabetes Care. 1987;10:238–248. doi: 10.2337/diacare.10.2.238. - DOI - PubMed

LinkOut - more resources